Newbornscreening SMA – From Pilot Project to Nationwide Screening in Germany
Journal of Neuromuscular Diseases · 03.01.2023 · 10 (1) · 55-65
DOI: 10.3233/jnd-221577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, online erschienen am 28.11.2022. Verfasst von Wolfgang Müller-Felber und 35 weiteren Autor:innen. Beteiligte Einrichtung: Dr. v. Hauner Children's Hospital, Department of Pediatric Neurology and Developmental Medicine, LMU - University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Now that targeted therapies for spinal muscular atrophy are available, attempts are being made worldwide to include screening for spinal muscular atrophy in general newborn screening. In Germany, after pilot projects from 2018–2021, it was included in the general newborn screening from October 2021. To ensure a smooth transition, criteria for follow-up were developed together with key stakeholders. At the beginning of the transition to nationwide screening, false positive findings were reported in 3 patients. After optimization of the screening method in the laboratories concerned, all findings have been subsequently confirmed. On average, the first presentation to a neuromuscular center occurred on day 12 of life, and in patients with 2 or 3 SMN2 copies, therapy started on day 26 of life. Compared with the pilot project, there was no significant delay in timing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dr. v. Hauner Children's Hospital, Department of Pediatric Neurology and Developmental Medicine, LMU - University of Munich, Munich, Germany.
- Department of Pediatric Neurology, Muenster University Hospital, Münster, Germany.
- MVZ Genetikum GmbH, Center for Human Genetics, Neu-Ulm, Germany.
- Screening Center of the Bavarian Health and Food Safety Authority, Oberschleissheim, Germany.
- Institute of Human Genetics, Center for Molecular Genetics Cologne and Center for Rare Diseases Cologne, University of Cologne, Cologne, Germany.
- Labor Becker und Kollegen, Munich, Germany.
Zitieren
APA
Müller-Felber, W., Blaschek, A., Schwartz, O., Gläser, D., Nennstiel, U., Brockow, I., Wirth, B., Burggraf, S., Röschinger, W., Becker, M., Durner, J., Eggermann, K., Kölbel, H., Müller, C., Hannibal, I., Olgemöller, B., Schara, U., von Moers, A., Trollmann, R., …, & Vill, K. (2023). Newbornscreening SMA – From Pilot Project to Nationwide Screening in Germany. Journal of Neuromuscular Diseases, 10(1), 55-65. https://doi.org/10.3233/jnd-221577
Vancouver
Müller-Felber W, Blaschek A, Schwartz O, Gläser D, Nennstiel U, Brockow I, et al. Newbornscreening SMA – From Pilot Project to Nationwide Screening in Germany. Journal of Neuromuscular Diseases. 2023;10(1):55-65. doi:10.3233/jnd-221577
BibTeX
@article{MllerFelber2023,
author = {Müller-Felber, Wolfgang and Blaschek, Astrid and Schwartz, Oliver and Gläser, Dieter and Nennstiel, Uta and Brockow, Inken and Wirth, Brunhilde and Burggraf, Siegfried and Röschinger, Wulf and Becker, Marc and Durner, Jürgen and Eggermann, Katja and Kölbel, Heike and Müller, Christine and Hannibal, Iris and Olgemöller, Bernd and Schara, Ulrike and von Moers, Arpad and Trollmann, Regina and Johannssen, Jessika and Ziegler, Andreas and Cirak, Sebahattin and Hahn, Andreas and von der Hagen, Maja and Weiss, Claudia and Schreiber, Gudrun and Flotats-Bastardas, Marina and Hartmann, Hans and Illsinger, Sabine and Pechmann, Astrid and Horber, Veronka and Kirschner, Jan and Köhler, Cornelia and Winter, Benedikt and Friese, Johannes and Vill, Katharina},
title = {Newbornscreening SMA – From Pilot Project to Nationwide Screening in Germany},
journal = {Journal of Neuromuscular Diseases},
year = {2023},
volume = {10},
number = {1},
pages = {55--65},
doi = {10.3233/jnd-221577}
}
EUVIMED